Loss of TINCR leads to stress-induced ATF4 activation, immune evasion, and resistance to BRAF/MEK inhibitors in melanoma cells, highlighting its role at the intersection of immune regulation and tumor progression (34). Here, TINCR is linked to neoplasm.